Paylocity (PCTY) Form 4: CFO Sells 1,303 Shares, Retains 80,410

Rhea-AI Filing Summary

Paylocity Holding Corp (PCTY) Chief Financial Officer Glenn Ryan reported sales of common stock executed on 08/19/2025 under an approved 10b5-1 plan adopted November 20, 2024. The Form 4 shows three sell transactions totaling 1,303 shares at weighted-average prices reported as $177.4 and $178.89, with an individual sale at $179.49; prices in the footnotes ranged from $177.14 to $179.43. After these transactions the reporting person beneficially owned 80,410 shares. The filing was signed by attorney-in-fact Kris Kang on 08/21/2025.

Positive

• Transactions conducted under an approved 10b5-1 plan, indicating pre-scheduled trades rather than ad-hoc insider sales
• Full pricing ranges disclosed with weighted-average prices and an offer to provide detailed breakdowns upon request, supporting transparency

Negative

• Insider sold 1,303 shares on 08/19/2025, reducing beneficial ownership to 80,410 shares
• Sales include high-price executions (prices ranged up to $179.49), which may be perceived negatively by some investors despite being pre-planned

Insights

Financial Analyst

TL;DR: Insider sales under a pre-established 10b5-1 plan totaling 1,303 shares; appears procedural rather than a company-specific signal.

The reported transactions are sales by the CFO executed pursuant to an approved 10b5-1 trading plan, indicating pre-scheduled dispositions rather than discretionary trades. Total shares sold (1,303) reduced beneficial ownership to 80,410 shares. Transaction prices and ranges are disclosed, with weighted-average figures provided. For investors, such filings confirm compliance and provide transparency on insider liquidity, but the size relative to total holdings is modest and the filing contains no operational or financial performance data.

Corporate Governance Expert

TL;DR: Proper disclosure and use of a 10b5-1 plan, signed by attorney-in-fact, consistent with governance best practices.

The Form 4 documents adherence to a pre-approved trading plan adopted 11/20/2024 and includes weighted-average pricing and a commitment to provide granular sale data upon request. Signature by an attorney-in-fact is noted. These elements reflect strong procedural compliance with insider trading rules. The disclosure is routine and does not contain any governance anomalies or indications of undisclosed related-party transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glenn Ryan

(Last) (First) (Middle)

C/O 1400 AMERICAN LANE

(Street)

SCHAUMBURG IL 60173

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Paylocity Holding Corp [ PCTY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001	08/19/2025		S		703(1)	D	$177.4(2)	81,010	D
Common Stock, par value $0.001	08/19/2025		S		500(1)	D	$178.89(3)	80,510	D
Common Stock, par value $0.001	08/19/2025		S		100(1)	D	$179.49	80,410	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on November 20, 2024.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $177.14 to $177.86, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3 of this Form 4.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $178.46 to $179.43, inclusive.

Remarks:

	/s/ Kris Kang, attorney-in-fact to Ryan Glenn	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PCTY CFO Glenn Ryan report on Form 4?

He reported sales of 1,303 shares of Paylocity common stock executed on 08/19/2025 under a 10b5-1 plan, leaving him with 80,410 shares.

Were the sales by Glenn Ryan part of a trading plan?

Yes. The filing states the transactions were conducted under an approved 10b5-1 plan adopted November 20, 2024.

What prices were reported for the sales?

Weighted-average prices are reported as $177.4 and $178.89 for grouped sales, and an individual sale at $179.49; disclosed ranges ran from $177.14 to $179.43.

When were the transactions and when was the Form 4 signed?

Transactions occurred on 08/19/2025 and the Form 4 was signed by attorney-in-fact Kris Kang on 08/21/2025.

Does the filing indicate any acquisitions or derivative transactions?

No. The Form 4 only reports non-derivative sales of common stock; Table II (derivatives) contains no reported transactions.